ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
110211-25MG |
|
956610-76-7 |
(6aR)-14-Hydroxy-6,7-diphenyl-14-oxide-dinaphtho[1,2-d:2',1'-f][1,3,2]dioxaphosphepin ≥98%,99%e.e. |
25MG | C32H21O4P | |
110192-1G |
|
871130-17-5 |
(8aS)-18-Hydroxy-8,9-diphenyl-18-oxide-diphenanthro[4,3-d:3',4'-f][1,3,2]dioxaphosphepin ≥98%,99%e.e. |
1G | C40H25O4P | |
110192-100MG |
|
871130-17-5 |
(8aS)-18-Hydroxy-8,9-diphenyl-18-oxide-diphenanthro[4,3-d:3',4'-f][1,3,2]dioxaphosphepin ≥98%,99%e.e. |
100MG | C40H25O4P | |
110192-25MG |
|
871130-17-5 |
(8aS)-18-Hydroxy-8,9-diphenyl-18-oxide-diphenanthro[4,3-d:3',4'-f][1,3,2]dioxaphosphepin ≥98%,99%e.e. |
25MG | C40H25O4P | |
110191-1G |
|
871130-18-6 |
(8aR)-18-Hydroxy-8,9-diphenyl-18-oxide-diphenanthro[4,3-d:3',4'-f][1,3,2]dioxaphosphepin ≥98%,99%e.e. |
1G | C40H25O4P | |
110191-100MG |
|
871130-18-6 |
(8aR)-18-Hydroxy-8,9-diphenyl-18-oxide-diphenanthro[4,3-d:3',4'-f][1,3,2]dioxaphosphepin ≥98%,99%e.e. |
100MG | C40H25O4P | |
110191-25MG |
|
871130-18-6 |
(8aR)-18-Hydroxy-8,9-diphenyl-18-oxide-diphenanthro[4,3-d:3',4'-f][1,3,2]dioxaphosphepin ≥98%,99%e.e. |
25MG | C40H25O4P | |
137842-1G |
|
NA |
(11aS)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e. |
1G | C49H35O4P | |
137842-100MG |
|
NA |
(11aS)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e. |
100MG | C49H35O4P | |
137842-25MG |
|
NA |
(11aS)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e. |
25MG | C49H35O4P | |
137841-1G |
|
NA |
(11aR)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e. |
1G | C49H35O4P | |
137841-100MG |
|
NA |
(11aR)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e. |
100MG | C49H35O4P | |
137841-25MG |
|
NA |
(11aR)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e. |
25MG | C49H35O4P | |
137792-1G |
|
NA |
(11aS)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e. |
1G | C35H35O4P | |
137792-100MG |
|
NA |
(11aS)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e. |
100MG | C35H35O4P | |
137792-25MG |
|
NA |
(11aS)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e. |
25MG | C35H35O4P | |
137791-1G |
|
1801196-27-9 |
(11aR)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e. |
1G | C35H35O4P | |
137791-100MG |
|
1801196-27-9 |
(11aR)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e. |
100MG | C35H35O4P | |
137791-25MG |
|
1801196-27-9 |
(11aR)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e. |
25MG | C35H35O4P | |
137782-1G |
|
NA |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e. |
1G | C47H59O6P | |